Quarterly Result5 Nov 2026, 05:04 pm
Gujarat Terce Labs Declares Q2 FY27 Unaudited Standalone Results
AI Summary
Gujarat Terce Laboratories Limited announced its Unaudited Standalone Financial Results for the second quarter and half-year ended September 30, 2026. The Board of Directors approved these results, which have undergone a limited review by the statutory auditor. The company operates in the pharmaceutical segment. The results were prepared in accordance with Indian Accounting Standards (Ind AS).
Key Highlights
- Board approved Unaudited Standalone Financial Results for Q2 and H1 FY27.
- Results are subjected to a limited review by the statutory auditor.
- Company operates in a single pharmaceutical segment.
- Financial results prepared in accordance with Ind AS.
- Board meeting held on November 5, 2026, concluded the approval process.
Price Impact
More from GUJTERC